ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 86 • 2012 ACR/ARHP Annual Meeting

    Longitudinal Hypertension Diagnosis and Control Among a Primary Care Medically Homed Population with Rheumatoid Arthritis

    Katya Voelker1 and Christie M. Bartels2, 1Univ of Wisconsin School of Medicine and Public Health, Madison, AA, 2Rheumatology/Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI

    Longitudinal Hypertension Diagnosis and Control among a Primary Care Medically Homed Population with Rheumatoid ArthritisBackground/Purpose: Hypertension is a key risk factor for cardiovascular disease (CVD)…
  • Abstract Number: 46 • 2012 ACR/ARHP Annual Meeting

    Synovitis in Secondary Osteoarthritis Due to Rheumatoid Arthritis: A Proof-of-Concept Study

    Stefan Vordenbäumen1, Tim Lögters2, Philipp Sewerin1, Thomas Pauly3, Ellen Bleck4, Paulina Philippski1, Matthias Schneider1, Michael Schädel-Höpfner2 and Benedikt Ostendorf1, 1Endocrinology, Diabetology and Rheumatology, Heinrich-Heine-University, Düsseldorf, Germany, 2Trauma and Hand Surgery, Heinrich-Heine-University, Düsseldorf, Germany, 3Orthopaedics, Rheinisches Rheumazentrum St. Elisabeth-Hospital, Meerbusch, Germany, 4Rheumatology, Heinrich-Heine-University, Düsseldorf, Germany

    Background/Purpose: Rheumatoid arthritis (RA) is characterized by considerable synovial inflammation which may result in secondary osteoarthritis (sOA). Primary OA (pOA) occurs in patients without predisposing…
  • Abstract Number: 47 • 2012 ACR/ARHP Annual Meeting

    Accumulation of CD34+ Hematopoietic Stem Cells in the Initial Inflammatory Human Fracture Hematoma Is Mediated Via Chemokine Receptor Type 3 Ligands

    Paula Hoff1, Timo Gaber1, Martin Hahne1, Cindy Strehl1, Katharina Schmidt-Bleek2, Gerd Burmester3, Gerhard Schmidmaier4, Georg Duda5, Carsten Perka6 and Frank Buttgereit7, 1Department of Rheumatology and Clinical Immunology, Charité University Medicine, Berlin, Germany, 2Julius Wolff Institut, Charité University Medicine, Berlin, Germany, 3Department of Rheumatology and Clinical Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany, 4Department of Traumatology, Heidelberg University Hospital, Heidelberg, Germany, 5Julius Wolff Institute, Charité – Universitätsmedizin Berlin, Berlin, Germany, 6Center of Muscoloskeletal Surgery, Charité University Medicine, Berlin, Germany, 7Charité - Universitätsmedizin Berlin, Berlin, Germany

    Background/Purpose: We have previously shown the early phase of human fracture healing to be characterized by hypoxia which promotes inflammation and chemoattraction. Hypoxia is also…
  • Abstract Number: 48 • 2012 ACR/ARHP Annual Meeting

    Tissue Engineering for Articular Cartilage Repair, Culturing Bone Marrow Mesenchymal Stem Cells On Collagen and Heparan Sulphate Scaffolds

    Adela Helvia Martinez-Sanchez1, Clara Sanjurjo-Rodriguez1, Silvia Diaz-Prado2, Emma Muiños1, Isaac M. Fuentes2, Francisco J. De Toro2, Julia Bujan3 and Francisco J. Blanco1, 1Osteoarticular and Aging Res. Lab. CIBER-BBN. Rheumatology Div. INIBIC-Complejo Hosp. Univ. A Coruña, A Coruña, Spain, 2Osteoarticular and Aging Res. Lab. CIBER-BBN. INIBIC-University of A Coruña, A Coruña, Spain, 3Department of Medical Specialties. University of Alcala de Henares, Madrid, Spain

     Background/Purpose: The aim of this study was to evaluate the chondrogenic potential of bone marrow mesenchymal stem cells (BM-MSCs) grown on type I collagen and…
  • Abstract Number: 49 • 2012 ACR/ARHP Annual Meeting

    The Spatial Energy Expenditure Configuration and Possible Applications in an Experimental Model of Arthritis

    Susanne Klatt1 and Rainer H. Straub2, 1Department of Internal Medicine I, Laboratory of Exp. Rheumatology and Neuroendocrine Immunology, University Hospital Regensburg, Regensburg, 93055, Germany, 2Department of Internal Medicine 1, University Hospital Regensburg, Regensburg, Germany

    Background/Purpose: An autoimmune response with differentiation and proliferation of immune cells and the subsequent tissue-directed inflammatory process in the symptomatic phase of the disease are…
  • Abstract Number: 50 • 2012 ACR/ARHP Annual Meeting

    Human Chondrocyte Dedifferentiation Is Accompagnied by CD105 Endoglin Expression, ALK-1/Smad1/5 Phosphorylation and Leptin Production – Stimulation by Prednisolone and Aldosterone Through the Glucocorticoid Receptor

    Olivier Malaise1, Biserka Relic2, Mustapha Zeddou1, Edith Charlier1, Florence Quesada Calvo1, Sophie Neuville3, Dominique de Seny2 and Michel G. Malaise4, 1Department of Rheumatology, GIGA Research - University of Liège - CHU Liège, Liège, Belgium, 2Department of Rheumatology, GIGA Research - University of Liège - CHU of Liège, Liège, Belgium, 3GIGA Research - University of Liège - CHU of Liège, Liège, Belgium, 4Department of Rheumatology, University of Liège - CHU Liège, Liège, Belgium

    Background/Purpose:   Leptin, mainly produced by the adipose tissue including fat neighboring the joint, is considered as pro-inflammatory in osteoarthritis (OA). Normal cartilage does not…
  • Abstract Number: 51 • 2012 ACR/ARHP Annual Meeting

    Phosphodiesterase 4 Expression in Rheumatoid Arthritis Synovium and Anti-Inflammatory Effects of Apremilast On Synovial Fibroblasts

    Lei Wu, Mary Adams, Stacey Parton and Peter Schafer, Department of Translational Development, Celgene Corporation, Summit, NJ

    Background/Purpose: Apremilast (APR), a small molecule specific inhibitor of phosphodiesterase 4 (PDE4), works intracellularly to modulate pro- and anti-inflammatory mediator production in both immune and…
  • Abstract Number: 52 • 2012 ACR/ARHP Annual Meeting

    The Validity of the Diagnosis Inflammatory Arthritis in Primary Care

    Markus M.J. Nielen1, Jennie Ursum1, François G. Schellevis2 and Joke C. Korevaar1, 1NIVEL (Netherlands Institute for Health Services Research), Utrecht, Netherlands, 2Department of General Practice and Elderly Care Medicine/EMGO Institute for Health and Care Research, VU University Medical Centre, Amsterdam, Netherlands

    Background/Purpose: Large population-based databases, such as electronic medical records (EMRs) from patients in primary care, are useful data sources to investigate morbidity and health care…
  • Abstract Number: 53 • 2012 ACR/ARHP Annual Meeting

    Comparison of Decision Rules for Identifying Patients with Rheumatoid Arthritis (RA) in Administrative Healthcare Databases

    John G. Hanly, Kara Thompson and Chris Skedgel, Division of Rheumatology, Dalhousie University and Capital Health, Halifax, NS, Canada

    Background/Purpose: Identification of RA cases in administrative healthcare databases is used to estimate disease frequency, healthcare utilization and cost for RA. However, the optimal methodology…
  • Abstract Number: 54 • 2012 ACR/ARHP Annual Meeting

    Use of Health Plan Data to Assess Feasibility of Large Pragmatic Clinical Trials in Rheumatoid Arthritis

    Jeffrey R. Curtis1, Lang Chen2, Fenglong Xie3, Jie Zhang1, Kenneth G. Saag4, Stacey Cofield5, Kevin L. Winthrop6, Nicole C. Wright7 and Elizabeth S. Delzell8, 1Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL, 2Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL, 3Rheumatology & Immunology, University of Alabama at Birmingham, Birmingham, AL, 4Div Clinical Immun & Rheum, Univ of Alabama-Birmingham, Birmingham, AL, 5School of Public Health, Department of Biostatistics, Univ of Alabama at Birmingham,, Birmingham, AL, 6Dept of Infectious Disease, Oregon Health & Science University, Portland, OR, 7Epidemiology, The University of Alabama at Birmingham, Birmingham, AL, 8Epidemiology, University of Alabama at Birmingham, Birmingham, AL

    Background/Purpose: Large pragmatic clinical trials (PCTs) are increasingly used to conduct comparative effectiveness research (CER). PCTs typically have simple inclusion/exclusion criteria and hard outcomes (e.g.…
  • Abstract Number: 55 • 2012 ACR/ARHP Annual Meeting

    Accuracy of Canadian Health Administrative Databases in Identifying Patients with Rheumatoid Arthritis Seen by Rheumatologists

    Jessica Widdifield1, Sasha Bernatsky2, J. Michael Paterson3, Karen Tu3, Ryan Ng3, J. Carter Thorne4, Janet E. Pope5 and Claire Bombardier6, 1University of Toronto, Toronto, ON, Canada, 2Clinical Epidemiology, Research Institute of the McGill University Health Ctre, Montreal, QC, Canada, 3Institute for Clinical Evaluative Sciences, Toronto, ON, Canada, 4Southlake Regional Health Centre, Newmarket, ON, Canada, 5Medicine/Rheumatology, St. Joseph Health Care London, University of Western Ontario, London, ON, Canada, 6Rheumatology, University of Toronto, Toronto, ON, Canada

    Background/Purpose: In a predominantly universal single-payer health system, Canadian health administrative data are a valuable tool and increasingly used for research. Few studies have rigorously…
  • Abstract Number: 56 • 2012 ACR/ARHP Annual Meeting

    A Validated Mathematical Model Using Electronic Health Records to Identify Rheumatoid Arthritis Patients for Observational Studies

    Aarat M. Patel1, Ilinca D. Metes2, Larry W. Moreland3, Melissa Saul4, Stephen R. Wisniewski5 and Marc C. Levesque6, 1Rheumatology & Clinical Immun / Pediatric Rheumatology, Univ of Pittsburgh Med Ctr / Children's Hospital of Pittsburgh of UPMC, Pittsburgh, PA, 2Department of Medicine, Division of Clinical Immunology and Rheumatology, University of Pittsburgh, Pittsburgh, PA, 3Division of Rheumatology & Clinical Immunology, University of Pittsburgh, Pittsburgh, PA, 4Biomedical Informatics, University of Pittsburgh, School of Medicine, Pittsburgh, PA, 5Epidemiology, University of Pittsburgh, Graduate School of Public Health, Pittsburgh, PA, 6Division of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, PA

    Background/Purpose: To develop and validate a search algorithm with a high specificity and sensitivity to identify rheumatoid arthritis (RA) patients in a large health care…
  • Abstract Number: 57 • 2012 ACR/ARHP Annual Meeting

    A British Survey of Time to Presentation and Treatment of Rheumatoid Arthritis in Subjects of Black and Minority Ethnic Origin

    Sonia Panchal1, Ash Samanta1, Arumugam Moorthy1, Sawson Hayat2, Ira Pande2, Adewale O. Adebajo3 and Kuntal Chakravarty4, 1Rheumatology, University Hospitals of Leicester, Leicester, United Kingdom, 2Rheumatology, Nottingham University Hospitals, Nottingham, United Kingdom, 3Faculty of Medicine, Dentistry and Health, University of Sheffield, Sheffield, United Kingdom, 4Dept of Rheumatology, University of Bedfordshire Post Graduate Medical School, Romford, United Kingdom

    Background/Purpose: National guidelines mandate urgent referral of rheumatoid arthritis (RA) for specialist treatment if more than three months from symptom onset; initial combination therapy with…
  • Abstract Number: 58 • 2012 ACR/ARHP Annual Meeting

    5 Million Patients and Not 0.34% Is Worrisome: Burden of Rheumatoid Arthritis in India Based On a Bone and Joint Decade India Community Oriented Program for Control of Rheumatic Disease

    Arvind Chopra1, R. Ghorpade2, S. Sarmukkadam3, VL Joshi1, AJ. Mathews4, L. Gauri5, A. Rahim6, K. Datta7, S. Chaturvedi8, B. Thakuria9, A. Mahajan10, R. Singh11, A. Ghosh12, R. Handa13, Manjit Saluja14, A. Venugopalan1, V. Kunjeer1, B. Paul6, S. Pal7, K. Wangjam11, T. Kumar15 and K. Mahendranath16, 1Rheumatology, Center for Rheumatic Diseases, Pune, India, 2Center for Rheumatic Diseases, Pune, India, 3BJMC, Pune, India, 4Government Medical College Hospital, Trivandrum, India, 5SP Medical College, Bikaner, India, 6Calicut Medical College, Calicut, India, 7Advance Rheumatology Clinic, Hyderabad, India, 8FRCH, Pune, India, 9Guwahati Medical College & Hospital, Guwahati, India, 10Government Medical College, Jammu, India, 11Regional Institute of Medical Sciences, Imphal, Manipur, India, 12Rheumatology, Institute of Post Graduate Medical Education and Research, Kolkata, India, 13Department of Rheumatology, AIIMS, New Delhi, India, 14Clinical care, Center for Rheumatic Diseases, Pune, India, 15Institute of Post Graduate Medical Education and Research, Kolkata, India, 16Rheumatology Clinic, Bangalore, India

    Background/Purpose : The 1 % prevalence of RA Worldwide is a deep rooted ancient dogma. None of the recent WHO ILAR COPCORD (Community Oriented Program…
  • Abstract Number: 59 • 2012 ACR/ARHP Annual Meeting

    A Staggering Burden of Pain and Rheumatic Disorders in India: A National Bone & Joint Decade India Community Oriented Program for Control of Rheumatic Disease Survey 2006-2011

    Arvind Chopra1, R. Ghorpade1, S. Sarmukkadam2, VL Joshi1, AJ. Mathews3, L. Gauri4, A. Rahim5, K. Datta6, S. Chaturvedi7, B. Thakuria8, A. Mahajan9, R. Singh10, A. Ghosh11, R. Handa12, Manjit Saluja13, A. Venugopalan14, V. Kunjeer14, B. Paul5, S. Pal6, K. Wangjam10, T. Kumar15, CP Rajendran16, V. Gajalakshmi17 and K. Mahendranath18, 1Rheumatology, Center for Rheumatic Diseases, Pune, India, 2Biostatistics, B J Medical College, Pune, India, 3Government Medical College Hospital, Trivandrum, India, 4SP Medical College, Bikaner, India, 5Calicut Medical College, Calicut, India, 6Advance Rheumatology Clinic, Hyderabad, India, 7FRCH, Pune, India, 8Guwahati Medical College & Hospital, Guwahati, India, 9Government Medical College, Jammu, India, 10Regional Institute of Medical Sciences, Imphal, Manipur, India, 11Rheumatology, Institute of Post Graduate Medical Education and Research, Kolkata, India, 12Department of Rheumatology, AIIMS, New Delhi, India, 13Clinical care, Center for Rheumatic Diseases, Pune, India, 14Center for Rheumatic Diseases, Pune, India, 15Institute of Post Graduate Medical Education and Research, Kolkata, India, 16Madras Medical College, Chennai, India, 17ERC Unit, Chennai, India, 18Rheumatology clinic, Bangalore, India

    Background/Purpose : The maiden COPCORD (Community Oriented Program for Control of Rheumatic Diseases) population survey in village Bhigwan (Pune) findings proposed a high burden of…
  • « Previous Page
  • 1
  • …
  • 2415
  • 2416
  • 2417
  • 2418
  • 2419
  • …
  • 2425
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology